Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04131543
Title Phase II Study With Cabozantinib in Patients With RET Positive NSCLC (CRETA)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Bologna
Indications

lung non-small cell carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
OU di Oncologia Medica- Azienda ospedaliero-Universitaria S. Orsola Malpighi Recruiting Bologna 40138 Italy Details
U.O di Oncologia Medica Policlinico V.Emanuele-G.Rodolico Not yet recruiting Catania 95125 Italy Details
Oncologia Medica 2 -Policlinico San Martino Not yet recruiting Genova 16132 Italy Details
S.S. di Oncologia Medica toraco-polmonare - Fondazione IRCCS - Istituto Nazionale Tumori Not yet recruiting Milano 20133 Italy Details
U.O.C Pneumologia ad Indirizzo Oncologico -AORN Ospedali dei Colli Monaldi-Cotugno-CTO Not yet recruiting Napoli 80131 Italy Details
UOC di Oncologia Medica 2 - IOV Istituto Oncologico Veneto Not yet recruiting Padova 35128 Italy Details
UOC di Oncologia Medica- Azienda Ospidaliero Universitaria di Parma Not yet recruiting Parma 43126 Italy Details
US di Oncologia Medica - A.O. di Perugia Not yet recruiting Perugia 06132 Italy Details
UO Pneumologia - A.O.U Pisana Not yet recruiting Pisa 56126 Italy Details
S.C. di Oncologia Medica - IFO - Istituto Regina Elena Not yet recruiting Roma 00144 Italy Details
UOC di Oncologia Medica - Azienda Sanitaria Universitaria Integrata di Udine Not yet recruiting Udine 33100 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field